These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians. Drake T; Landsteiner A; Langsetmo L; MacDonald R; Anthony M; Kalinowski C; Ullman K; Billington CJ; Kaka A; Sultan S; Wilt TJ Ann Intern Med; 2024 May; 177(5):618-632. PubMed ID: 38639549 [TBL] [Abstract][Full Text] [Related]
24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
25. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Sowers JR; Frohlich ED Med Clin North Am; 2004 Jan; 88(1):63-82. PubMed ID: 14871051 [TBL] [Abstract][Full Text] [Related]
26. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes. Hoerger TJ; Ahmann AJ J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890 [TBL] [Abstract][Full Text] [Related]
27. How to Manage Hypertension in People With Diabetes. Ali W; Bakris GL Am J Hypertens; 2020 Oct; 33(10):935-943. PubMed ID: 32307510 [TBL] [Abstract][Full Text] [Related]
28. Evidence for Cardiorenal Protection with SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Patients with Diabetic Kidney Disease. Georgianos PI; Vaios V; Roumeliotis S; Leivaditis K; Eleftheriadis T; Liakopoulos V J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207711 [TBL] [Abstract][Full Text] [Related]
29. RSSDI Guidelines for the management of hypertension in patients with diabetes mellitus. Kumar V; Agarwal S; Saboo B; Makkar B Int J Diabetes Dev Ctries; 2022 Oct; 42(4):576-605. PubMed ID: 36536953 [TBL] [Abstract][Full Text] [Related]
30. [Pathophysiological mechanisms of major mental disorders related to cardiovascular disease]. Theodosis-Nobelos P; Asimakopoulou E; Madianos M Psychiatriki; 2022 Jun; 33(2):113-123. PubMed ID: 34390565 [TBL] [Abstract][Full Text] [Related]
31. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Khan NA; McAlister FA; Rabkin SW; Padwal R; Feldman RD; Campbell NR; Leiter LA; Lewanczuk RZ; Schiffrin EL; Hill MD; Arnold M; Moe G; Campbell TS; Herbert C; Milot A; Stone JA; Burgess E; Hemmelgarn B; Jones C; Larochelle P; Ogilvie RI; Houlden R; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Dechamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Tobe S; Touyz RM; Can J Cardiol; 2006 May; 22(7):583-93. PubMed ID: 16755313 [TBL] [Abstract][Full Text] [Related]
32. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Khan NA; Hemmelgarn B; Padwal R; Larochelle P; Mahon JL; Lewanczuk RZ; McAlister FA; Rabkin SW; Hill MD; Feldman RD; Schiffrin EL; Campbell NR; Logan AG; Arnold M; Moe G; Campbell TS; Milot A; Stone JA; Jones C; Leiter LA; Ogilvie RI; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Burns KD; Ruzicka M; deChamplain J; Pylypchuk G; Gledhill N; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Touyz RM; Tobe SW; Can J Cardiol; 2007 May; 23(7):539-50. PubMed ID: 17534460 [TBL] [Abstract][Full Text] [Related]
33. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation]. Vanuzzo D; Pilotto L; Mirolo R; Pirelli S G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746 [TBL] [Abstract][Full Text] [Related]
34. A guide to the management of blood pressure in the diabetic hypertensive patient. Shammas NW; Sica DA; Toth PP Am J Cardiovasc Drugs; 2009; 9(3):149-62. PubMed ID: 19463021 [TBL] [Abstract][Full Text] [Related]
35. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484 [TBL] [Abstract][Full Text] [Related]
36. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Kones R Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295 [TBL] [Abstract][Full Text] [Related]
37. Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes. de Bhailís ÁM; Azmi S; Kalra PA Ther Adv Endocrinol Metab; 2021; 12():20420188211020664. PubMed ID: 34104399 [TBL] [Abstract][Full Text] [Related]
38. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension. Chiang CE; Wang TD; Li YH; Lin TH; Chien KL; Yeh HI; Shyu KG; Tsai WC; Chao TH; Hwang JJ; Chiang FT; Chen JH; J Formos Med Assoc; 2010 Oct; 109(10):740-73. PubMed ID: 20970072 [TBL] [Abstract][Full Text] [Related]
39. Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease. Oikonomou E; Xenou M; Zakynthinos GE; Tsaplaris P; Lampsas S; Bletsa E; Gialamas I; Kalogeras K; Goliopoulou A; Gounaridi MI; Pesiridis T; Tsatsaragkou A; Vavouranakis M; Siasos G; Tousoulis D Curr Pharm Des; 2023; 29(23):1844-1862. PubMed ID: 37403390 [TBL] [Abstract][Full Text] [Related]